GlassScriptPhysician profile
Diana Torres
NPI 1861077802
$3,696.05
in general payments reported to CMS, 2019-2025
28 companies · $919 in 2025
The $919 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $537 · 2023: $876 · 2024: $903 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,698.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $440.22 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $384.77 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $331.10 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Grifols USA, LLC | $325.60 | 2022-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.81 | 2021-2025 | Ofev, Jascayd |
| Mallinckrodt Hospital Products INC. | $224.11 | 2021-2025 | Acthar |
| Genzyme Corporation | $205.81 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $182.19 | 2023-2025 | Winrevair, Zerbaxa, Dificid |
| United Therapeutics Corporation | $152.70 | 2022-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $125.23 | 2023-2025 | Glassia |
| Mylan Specialty L.P. | $121.94 | 2021-2024 | Yupelri |
| Baxter Healthcare | $118.39 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $85.63 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $73.25 | 2021-2024 | Ultomiris |
| Gilead Sciences, INC. | $70.62 | 2021-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $65.99 | 2023-2025 | |
| Insmed, INC. | $58.98 | 2025 | Arikayce, Brinsupri |
| Philips North America LLC | $56.86 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Inari Medical, INC. | $50.47 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Electromed, INC. | $49.67 | 2023-2025 | Smartvest |
| Aimmune Therapeutics, INC. | $42.57 | 2025 | Zenpep |
| Ani Pharmaceuticals, INC. | $40.22 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $36.37 | 2024-2025 | Uptravi, Opsynvi |
| Advanced Respiratory, INC | $31.39 | 2021 | |
| Chiesi USA, INC. | $28.53 | 2023 | Bronchitol |
| Harmony Biosciences LLC | $27.68 | 2022 | |
| Inspire Medical Systems, INC. | $21.05 | 2025 | Inspire |
| Amgen INC. | $19.90 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.